ELV241220P420000
- 53.95
- +1.85+3.55%
Elevance Health Newsroom
Elevance Health Stock Plunges 29.6% in Q4: Buy, Hold or Sell?
U.S. Healthcare Spending Climbs 7.5% in 2023
Your Healthcare Costs Are Soaring! US Spending Reached $5 Trillion In 2023 With Major Increase in Obesity and Diabetes Drugs, Hospital Services
25 U.S. 'Highest Conviction' Stocks – UBS
The Medical assistance program may come under pressure as Morgan Stanley downgrades Elevance Health (ELV.US).
Elevance Health (ELV.US) faces pressure in its Medical assistance Business, and Morgan Stanley downgraded the stock rating from "Shareholding" to "Hold" on Tuesday.
Elevance Downgraded at Morgan Stanley on Medicaid Headwinds
Health-care Sector Faces Mixed Prospects in 2025, Morgan Stanley Says
UnitedHealth, CVS Health Extend Decline as Pfizer CEO Cites Trump's PBM Comments
Morgan Stanley Downgrades Elevance Health(ELV.US) to Hold Rating, Cuts Target Price to $388
Morgan Stanley Sticks to Its Buy Rating for Elevance Health (ELV)
Worst Performing Stocks for Tax Loss Selling – Wolfe
The Return Trends At Elevance Health (NYSE:ELV) Look Promising
Insiders At Elevance Health Sold US$12m In Stock, Alluding To Potential Weakness
If You Invested $100 In This Stock 20 Years Ago, You Would Have This Much Today
What will be the impact on Medical Care stocks following the murder of the CEO of UnitedHealth?
The support for the murderer by the public in the USA reveals their long-standing resentment towards the Medical Care Industry, which may lead to a reckoning for that industry, and investors should be prepared for significant changes in this investment area.
Health Insurance Industry 'Laying Low' in Aftermath of UnitedHealthcare CEO Shooting
'Wanted' Signs Targeting Wall Street and Healthcare Executives Pop Up in New York City -- WSJ
Companies Tighten Security After a Health Care CEO's Killing Leads to a Surge of Threats
Peering Into Elevance Health's Recent Short Interest
Doctors Say Dealing With Health Insurers Is Only Getting Worse -- WSJ